News

Nov 12, 2019
HD 【Presentation】Financial Results for the First Half of Fiscal Year Ending March 31, 2020
Nov 8, 2019
HD Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2020
Oct 31, 2019
HD Integrated Report 2019
Oct 31, 2019
HD We updated sustainability web site
Oct 3, 2019
HD Meiji Added to the Dow Jones Sustainability Asia Pacific Index
Sep 26, 2019
HD Notice Concerning a Transfer of Shares due to the Transfer of a Consolidated Subsidary
Sep 26, 2019
PHARMA Meiji Seika Pharma reinforces Medreich’s pharmaceutical CMO/CDMO services and product supply for Japanese market
Sep 26, 2019
PHARMA DM Bio’s Biopharmaceutical manufacturing complies with Japanese GMP through PMDA inspection
Sep 20, 2019
PHARMA MEIJI AND EISAI ANNOUNCE PARKINSON’S DISEASE TREATMENT EQUFINA® TABLETS (SAFINAMIDE MESILATE) APPROVED IN JAPAN
Sep 17, 2019
HD Notice of the Establishment of a New Dairy Production and Sales Company in China
Aug 6, 2019
HD 【Presentation】Financial Results for the First Quarter of Fiscal Year Ending March 31, 2020
Aug 6, 2019
HD Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2020
Aug 5, 2019
HD Notice Concerning Completion of Payment in Full for Disposal of Treasury Stock for Restricted Stock Compensation
July 31, 2019
HD We updated ESG Data
July 16, 2019
HD Notice concerning the Disposal of Treasury Stock for Restricted Stock Compensation
June 13, 2019
HD Approach and Policy Concerning Lowering of Trading Unit
June 5, 2019
HD Notice of the 10th Ordinary General Meeting of Shareholders
May 17, 2019
HD 【Presentation】Financial Results for the Fiscal Year Ended March 31, 2019
May 13, 2019
HD Notice concerning surplus dividends
May 13, 2019
HD Consolidated Financial Results for the Fiscal Year Ended March 31, 2019
Mar 29, 2019
HD Tackling Deforestation in our Cocoa Supply Chain
Mar 27, 2019
HD Top Commitment to Sustainability
Feb 19, 2019
HD Notice of the Establishment of a New Research Laboratory – Co-Creation Center
Feb 7, 2019
HD 【Presentation】Financial Results for the Third quarter of Fiscal Year Ending March 31, 2019
Feb 7, 2019
HD Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2019
Jan 18, 2019
PHARMA Meiji Seika Pharma and Toray Reach Exclusive License Agreement on Antipuritic Agent TRK-820 in Thailand and Indonesia